Cargando…

Prognostic values of mid-radiotherapy (18)F-FDG PET/CT in patients with esophageal cancer

BACKGROUND: To identify whether early metabolic responses as determined using (18)F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) during radiotherapy (RT) predict outcomes in patients with esophageal cancer. METHODS: Twenty-one patients with esophageal cancer who r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Nalee, Cho, Hojin, Yun, Mijin, Park, Kyung Ran, Lee, Chang Geol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362604/ https://www.ncbi.nlm.nih.gov/pubmed/30717809 http://dx.doi.org/10.1186/s13014-019-1232-1

Ejemplares similares

Predictive value of interim (18)F-FDG-PET in patients with non-small cell lung cancer treated with definitive radiation therapy
por: Kim, Nalee, et al.
Publicado: (2020)

Imaging of Gastric Cancer Metabolism Using 18 F-FDG PET/CT
por: Yun, Mijin
Publicado: (2014)

Prognostic value of pretreatment (18)F-FDG PET-CT in radiotherapy for patients with hepatocellular carcinoma
por: Jo, In Young, et al.
Publicado: (2015)

Prognostic value of baseline (18)F-FDG PET/CT in patients with esophageal squamous cell carcinoma treated with definitive (chemo)radiotherapy
por: Xia, Lianshuang, et al.
Publicado: (2023)

Prognostic Value of Metabolic Tumor Volume Measured by 18F-FDG PET/CT in Esophageal Cancer Patients
por: Soydal, Çiğdem, et al.
Publicado: (2014)

Value of (18)F-FDG PET/MRI in the Preoperative Assessment of Resectable Esophageal Squamous Cell Carcinoma: A Comparison With (18)F-FDG PET/CT, MRI, and Contrast-Enhanced CT
por: Wang, Fei, et al.
Publicado: (2022)

Glucose Loading Enhances the Value of (18)F-FDG PET/CT for the Characterization and Delineation of Cerebral Gliomas
por: Kim, Dongwoo, et al.
Publicado: (2020)

Diagnostic Value of (18)F-FDG-PET/CT in Patients with FUO
por: Georga, Stamata, et al.
Publicado: (2020)

Value of 18-F-FDG PET/CT and CT in the Diagnosis of Indeterminate Adrenal Masses
por: Launay, Nathalie, et al.
Publicado: (2015)

Prognostic value of pretreatment (18)F-FDG PET-CT for nasopharyngeal carcinoma patients
por: Huang, Yecai, et al.
Publicado: (2017)

The Prognostic Value of (18)F-FDG PET/CT and KRAS Mutation in Colorectal Cancers
por: Arslan, Esra, et al.
Publicado: (2020)

Prognostic values of ALDOB expression and (18)F-FDG PET/CT in hepatocellular carcinoma
por: Jia, Wenzhi, et al.
Publicado: (2022)

The Prognostic and Diagnostic Value of [(18)F]FDG PET/CT in Untreated Laryngeal Carcinoma
por: Al-Ibraheem, Akram, et al.
Publicado: (2023)

Diagnostic value of (18)F-FDG-PET/CT in benign lung diseases
por: Ergonul, Ayse Gul, et al.
Publicado: (2018)

Differential diagnostic value of (18)F-FDG PET/CT in osteolytic lesions
por: Li, Xiaomeng, et al.
Publicado: (2020)

Prognostic value of nodal SUV(max) of (18)F-FDG PET/CT in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
por: Lee, So Jung, et al.
Publicado: (2017)

(18)F-FDG PET/CT Imaging In Oncology
por: Almuhaideb, Ahmad, et al.
Publicado: (2011)

Scar Sarcoidosis on (18)F-FDG PET/CT
por: Arora, Saurabh, et al.
Publicado: (2019)

18F-FDG PET/CT and COVID-19
por: Joob, Beuy, et al.
Publicado: (2020)

Prognostic Value of (18)F-FDG PET-CT in Nasopharyngeal Carcinoma: Is Dynamic Scanning Helpful?
por: Huang, Bingsheng, et al.
Publicado: (2015)

Prognostic Values of Baseline (18)F-FDG PET/CT in Patients with Peripheral T-Cell Lymphoma
por: Zhou, Yeye, et al.
Publicado: (2020)

Diagnostic and prognostic value of F-18 FDG PET/CT in patients with carcinoma of unknown primary
por: Bicakci, Nilufer
Publicado: (2022)

Predictive Value of [(18)F]FDG PET/CT for Lymph Node Metastasis in Rectal Cancer
por: Kim, Sung Hoon, et al.
Publicado: (2019)

Candida Esophagitis Incidentally Detected by 18F-FDG PET/CT in Metastatic Lung Adenocarcinoma
por: Martínez-Amador, N, et al.
Publicado: (2017)

Gross Tumor Delineation in Esophageal Cancer on MRI Compared With (18)F-FDG-PET/CT
por: Vollenbrock, Sophie E., et al.
Publicado: (2019)

Volumetric Evaluation of Staging (18)F-FDG PET/CT Images in Patients with Esophageal Cancer
por: Karahan Şen, Nazlı Pınar, et al.
Publicado: (2022)

The Efficacy of 18F-FDG PET/CT and Superparamagnetic Nanoferric Oxide MRI in the Diagnosis of Lung Cancer and the Value of 18F-FDG PET/CT in the Prediction of Lymph Node Metastasis
por: Yao, Lan, et al.
Publicado: (2021)

(18)F-FDG PET/CT Parameters for Predicting Prognosis in Esophageal Cancer Patients Treated With Concurrent Chemoradiotherapy
por: Lee, Seokmo, et al.
Publicado: (2021)

Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis
por: Fraum, Tyler J., et al.
Publicado: (2019)

Diagnostic Value of (18)F-FDG PET/CT in Patients with Carcinoma of Unknown Primary
por: Cengiz, Arzu, et al.
Publicado: (2018)

Value of (18)F-FDG PET/CT in the detection of occult malignancy in patients with dermatomyositis
por: Li, Xiuming, et al.
Publicado: (2020)

Clinical value of baseline (18)F-FDG PET/CT in soft tissue sarcomas
por: Reyes Marlés, Rafael Hernando, et al.
Publicado: (2021)

The Added Value of [(18)F]FDG PET/CT in the Management of Invasive Fungal Infections
por: Ankrah, Alfred O., et al.
Publicado: (2021)

Clinical value of (18)F-FDG PET/CT in the management of HIV-associated lymphoma
por: Liu, Qi, et al.
Publicado: (2023)

18F-FDG PET/CT as predictive and prognostic factor in esophageal cancer treated with combined modality treatment
por: Krengli, Marco, et al.
Publicado: (2022)

Added value of regional (18)F-FDG PET/MRI-assisted whole-body (18)F-FDG PET/CT in malignant ascites with unknown primary origin
por: Fu, Yiru, et al.
Publicado: (2023)

(11)C-Methionine PET/CT in Assessment of Multiple Myeloma Patients: Comparison to (18)F-FDG PET/CT and Prognostic Value
por: Morales-Lozano, Maria I., et al.
Publicado: (2022)

[(18)F]FAPI-42 PET/CT in differentiated thyroid cancer: diagnostic performance, uptake values, and comparison with 2-[(18)F]FDG PET/CT
por: Mu, Xingyu, et al.
Publicado: (2022)

The Prognostic Value of (18)F-FDG PET/CT for Hepatocellular Carcinoma Treated with Transarterial Chemoembolization (TACE)
por: Ma, Wenhui, et al.
Publicado: (2014)

Prognostic value of (18)F-FDG PET/CT metabolic parameters in small cell lung cancer
por: Choi, Eun Kyoung, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rai6ahms2q9h1egrjrer44bnb4